Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Veterinary drug residue colloidal gold testing is a rapid immunochromatographic screening technique used to detect antibiotic, antibacterial, and growth-promoting agent residues in food products of animal origin. Based on the highly specific binding between colloidal gold-labeled antibodies and target analytes, this lateral-flow method delivers visual results within minutes without requiring complex instrumentation. This article provides a comprehensive overview of the technology principle, applicable sample types, target analytes, testing procedures, practical applications, and frequently asked questions.

Technical Overview

The veterinary drug residue colloidal gold test, also known as the colloidal gold immunochromatographic assay (GICA) or lateral flow immunoassay (LFIA), is a rapid screening technology built on the principle of specific antigen-antibody immunoreaction. Colloidal gold nanoparticles, typically 15-40 nm in diameter, are conjugated to antibodies that recognize specific veterinary drug molecules. Because of the high electron density and intense red color of gold particles, the immune complex can be observed directly by the naked eye without any enzyme substrate development step.

A standard test strip consists of four functional components: a sample pad, a conjugate pad loaded with gold-labeled antibodies, a nitrocellulose membrane bearing a test line (T line) and a control line (C line), and an absorbent pad. When the liquid sample migrates through the strip by capillary action, target analytes in the sample interact with the gold-labeled antibodies and are captured at the lines, producing a visible color signal.

Because most veterinary drugs are small-molecule haptens (molecular weight generally below 1,000 Da) that cannot bind two antibodies simultaneously, the competitive inhibition format is adopted for the majority of residue tests. In this format, the analyte in the sample competes with the immobilized antigen on the T line for binding to the limited gold-labeled antibody. The intensity of the T line is inversely proportional to the analyte concentration in the sample.

The detection sensitivity of well-designed colloidal gold strips typically reaches the low parts-per-billion (ppb, μg/kg or μg/L) level, meeting or exceeding the maximum residue limits (MRLs) established by GB 31650, Commission Regulation (EU) No 37/2010, and Codex Alimentarius references. Total assay time, including extraction, is usually 20 to 40 minutes, with visual reading completed in 5 to 15 minutes.

Testing Samples

Animal Muscle Tissues

Skeletal muscle from livestock and poultry, including pork, beef, lamb, chicken, and duck, is the most common matrix. Muscle samples are trimmed of fat and connective tissue, homogenized, and extracted with an appropriate buffer before the strip is applied. This matrix directly reflects the residue status of edible meat products.

Animal Organs

Liver and kidney tissues are preferred targets for residue surveillance because lipophilic and protein-bound veterinary drugs accumulate and persist in these metabolic and excretory organs at concentrations higher than in muscle. Organ testing is therefore valuable for detecting violations of withdrawal periods even when muscle residues have depleted.

Aquatic Products

Fish (such as carp, tilapia, and pomfret), shrimp, crab, and shellfish are tested for residues of florfenicol, nitrofurans, sulfonamides, and quinolones, which are widely used in aquaculture. Sample preparation typically involves homogenization of edible tissue followed by buffer extraction and centrifugation.

Milk and Dairy Products

Raw milk at collection stations, pasteurized milk, and reconstituted milk powder are routinely screened for beta-lactams, tetracyclines, sulfonamides, and aminoglycosides. Milk is one of the simplest matrices, often requiring only dilution and degassing before direct application to the strip, enabling on-site screening within minutes.

Eggs and Egg Products

Whole egg homogenate is tested for residues of quinolones, macrolides, fipronil, and nitroimidazoles, which can transfer into eggs from medicated laying hens and persist through the production cycle.

Honey

Honey is screened for chloramphenicol, nitrofurans, nitroimidazoles, and sulfonamides used to control bee brood diseases. Due to the high viscosity and sugar content of honey, a dissolution and dilution step in buffer is required before testing.

Animal Urine, Serum, and Feed

Urine and serum samples from live animals allow non-destructive monitoring on farms, particularly for beta-agonists and antibiotic exposure before slaughter. Feed and drinking water samples can also be tested to trace the source of contamination in production chains.

Testing Items

Colloidal gold test strips cover all major classes of veterinary drugs regulated under national food safety standards and international MRL systems. Common screening targets include:

  • Beta-lactams: penicillin G, amoxicillin, ampicillin, cloxacillin, and cephalosporins
  • Tetracyclines: tetracycline, oxytetracycline, chlortetracycline, and doxycycline
  • Sulfonamides: sulfamethazine, sulfadiazine, sulfamonomethoxine, sulfadimidine, and total sulfonamide screening
  • Quinolones and fluoroquinolones: enrofloxacin, ciprofloxacin, norfloxacin, ofloxacin, and flumequine
  • Aminoglycosides: streptomycin, dihydrostreptomycin, gentamicin, kanamycin, and neomycin
  • Amphenicols: chloramphenicol, thiamphenicol, and florfenicol
  • Nitrofuran metabolites: AOZ (furazolidone), AMOZ (furaltadone), SEM (nitrofurazone), and AHD (nitrofurantoin)
  • Beta-adrenergic agonists: clenbuterol, ractopamine, salbutamol, and related compounds
  • Macrolides and lincosamides: erythromycin, tylosin, tilmicosin, and lincomycin
  • Other compounds: nitroimidazoles such as metronidazole and dimetridazole, avermectins, olaquindox, and quinoxaline derivatives

Testing Methods

The standard testing workflow consists of sample preparation, extraction, strip operation, and result interpretation, and can be performed by trained personnel at the point of sampling without laboratory infrastructure.

Sample preparation begins with homogenizing the tissue matrix, weighing a defined quantity (typically 1 to 5 grams), and extracting the analyte with a specified volume of extraction buffer. After vortex mixing and a short incubation, the mixture is centrifuged or allowed to settle, and the clear supernatant is used for testing. Liquid samples such as milk or urine usually require only dilution or direct application.

For strip operation, a measured volume of the extract (commonly 100 to 200 microliters) is added to the sample well or the strip is dipped into the extract to a marked depth. The liquid migrates across the membrane, and results are read within the specified window, generally 5 to 15 minutes, avoiding interpretation after the maximum reading time to prevent false judgments from background development.

Result interpretation for competitive-format strips follows these rules:

  • Negative: both the T line and the C line are visible, indicating the analyte concentration is below the cutoff of the strip
  • Positive: the C line is visible while the T line is absent or distinctly weaker than the reference, indicating the analyte concentration is at or above the cutoff
  • Invalid: the C line fails to appear regardless of the T line status, indicating the test has failed and must be repeated with a new strip

Quality control measures include running the test at the specified temperature (usually 15 to 30 degrees Celsius), protecting strips from humidity before use, observing the expiration date, and periodically verifying strip performance with certified reference materials or spiked controls. Positive screening results are presumptive only and must be confirmed using instrumental confirmatory methods such as HPLC or LC-MS/MS in accordance with relevant national standards before regulatory or commercial conclusions are drawn.

Applications

Colloidal gold testing is widely deployed across the entire food animal production and supply chain due to its speed, low cost, portability, and minimal operator training requirements. Typical application scenarios include:

  • Livestock, poultry, and aquaculture farms: monitoring withdrawal period compliance and screening for banned substances such as clenbuterol before animals are sent to market
  • Slaughterhouses and meat processing plants: rapid incoming inspection of live animals and carcasses to intercept residue-positive batches
  • Dairy collection stations and processing facilities: on-site screening of raw milk tankers for beta-lactam and tetracycline residues before unloading
  • Government food safety supervision and market surveillance: rapid screening at wholesale markets, supermarkets, and catering supply chains as part of routine enforcement sampling
  • Import and export inspection: first-line screening of animal-derived products at ports of entry to accelerate clearance and target samples for laboratory confirmation
  • Accredited third-party laboratories: high-throughput front-end screening to prioritize samples before confirmatory instrumental analysis, reducing overall testing cost and turnaround time

FAQ

Q: How sensitive is the veterinary drug residue colloidal gold test?

A: Well-manufactured strips achieve detection limits at the low ppb level, typically designed so the cutoff aligns with or falls below the corresponding MRL in GB 31650 or international regulations. Sensitivity varies by analyte class and matrix, and the labeled cutoff value should always be checked against the applicable regulatory limit.

Q: How long does a complete test take?

A: Visual reading takes 5 to 15 minutes after sample application. Including homogenization, extraction, and centrifugation, the entire procedure for tissue samples generally takes 20 to 40 minutes, allowing dozens of samples to be screened per hour by a single operator.

Q: Does a positive strip result mean the sample is non-compliant?

A: No. Colloidal gold tests are rapid screening methods, and a positive result is presumptive. Quantitative determination and legal conclusion require confirmatory analysis by HPLC or LC-MS/MS performed by accredited third-party laboratories or official control laboratories.

Q: Can the test provide quantitative results?

A: Standard strips are qualitative or semi-quantitative based on visual line intensity. When combined with a portable strip reader that measures optical density at the T and C lines, semi-quantitative concentration estimates can be generated for screening purposes.

Q: How should test strips be stored?

A: Strips should be stored sealed in their foil pouches with desiccant, typically at 2 to 8 degrees Celsius or as specified by the manufacturer, protected from moisture, direct sunlight, and freezing. Once the pouch is opened, the strip should be used promptly, generally within one hour under dry conditions.

Q: Is there cross-reactivity between drug classes?

A: Antibodies are designed for high specificity to the target analyte, but controlled cross-reactivity with structurally related compounds within the same drug class is often intentionally engineered to enable class screening, such as total sulfonamide or total quinolone detection. Cross-reactivity profiles are documented by the manufacturer and should be reviewed when interpreting results.